Humedix Co., Ltd. (KOSDAQ:200670)
43,950
-300 (-0.68%)
At close: Dec 5, 2025
Humedix Revenue
In the year 2021, Humedix had annual revenue of 110.99B KRW with 12.70% growth. Humedix had revenue of 30.37B in the quarter ending December 31, 2021, a decrease of -13.10%.
Revenue
110.99B
Revenue Growth
+12.70%
P/S Ratio
4.09
Revenue / Employee
447.55M
Employees
248
Market Cap
453.57B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |